{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:44:36Z","timestamp":1791960276414,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T00:00:00Z","timestamp":1095984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1038\/sj.eye.6701689","type":"journal-article","created":{"date-parts":[[2004,9,24]],"date-time":"2004-09-24T09:41:26Z","timestamp":1096018886000},"page":"841-845","source":"Crossref","is-referenced-by-count":69,"title":["Long-term treatment of refractory posterior uveitis with anti-TNF\u03b1 (infliximab)"],"prefix":"10.1038","volume":"19","author":[{"given":"J M","family":"Benitez-del-Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Martinez-de-la-Casa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Pato-Cour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"M\u00e9ndez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"L\u00f3pez-Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Matilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Garcia-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,9,24]]},"reference":[{"key":"BF6701689_CR1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1001\/archopht.1987.01060080119040","volume":"105","author":"JT Rosenbaum","year":"1987","unstructured":"Rosenbaum JT, Simples JR, Hefeneider SH, Howes Jr EL . Ocular inflammatory effects of intravitreal interleukin 1. Arch Ophthalmol 1987; 105: 1117\u20131120.","journal-title":"Arch Ophthalmol"},{"key":"BF6701689_CR2","first-page":"47","volume":"133","author":"JT Rosenbaum","year":"1988","unstructured":"Rosenbaum JT, Howes Jr EL, Rubin RM, Samples JR . Ocular inflammatory effects of intravitreally-injected tumor necrosis factor. Am J Pathol 1988; 133: 47\u201353.","journal-title":"Am J Pathol"},{"key":"BF6701689_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/BF00915816","volume":"14","author":"LN Feisher","year":"1990","unstructured":"Feisher LN, Ferrel JB, McGahan MC . Ocular inflammatory effects of intravitreally injected tumor necrosis factor-alpha and endotoxin. Inflammation 1990; 14: 325\u2013335.","journal-title":"Inflammation"},{"key":"BF6701689_CR4","first-page":"2211","volume":"37","author":"G Sartani","year":"1996","unstructured":"Sartani G, Silver PB, Rizzo LV, Chan CC, Wigert B, Mastorakos G et al. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting an antigen priming. Invest Ophthalmol Vis Sci 1996; 37: 2211\u20132218.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6701689_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","volume":"358","author":"PP Sfikakis","year":"2001","unstructured":"Sfikakis PP, Theodossiadis PG, Katsiari CG, Kaklamanis P, Markomichelakis NN . Effect of infliximab on sight-threatening panuveitis in Behcet's disease. Lancet 2001; 358: 295\u2013296.","journal-title":"Lancet"},{"key":"BF6701689_CR6","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, Van der Heijde DM, St Clair EW, Furst SE, Breedveld C, Kalden JR et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 2000; 343: 1594\u20131602.","journal-title":"N Engl J Med"},{"key":"BF6701689_CR7","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"SR Targan","year":"1997","unstructured":"Targan SR, Hanauer SB, Van Devetler SJ, Mayer L, Present DH, Braakman T et al. The Crohn's disease cA2 study group. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor for Crohn's disease. N Engl J Med 1997; 337: 1029\u20131035.","journal-title":"N Engl J Med"},{"key":"BF6701689_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","volume":"43","author":"J Brandt","year":"2000","unstructured":"Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Redding J et al. Successful treatment of active ankylosing spondylitis with anti-tumor necrosis factor alpha monoclonal antibody infliximab. Arthritis Rheum 2000; 43: 1346\u20131352.","journal-title":"Arthritis Rheum"},{"key":"BF6701689_CR9","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0161-6420(03)00406-8","volume":"110","author":"A Joseph","year":"2003","unstructured":"Joseph A, Raj D, Dua HS, Powell PT, Lanyon PC, Powell RJ . Infliximab in the treatment of refractory posterior uveitis. Ophthalmology 2003; 110: 1449\u20131453.","journal-title":"Ophthalmology"},{"key":"BF6701689_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","volume":"92","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt RB, Palestine AG, Chan CC, Roberge F . Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985; 92: 467\u2013471.","journal-title":"Ophthalmology"},{"key":"BF6701689_CR11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","volume":"111","author":"CC Murphy","year":"2004","unstructured":"Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, Jayne D . Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 2004; 111: 352\u2013356.","journal-title":"Ophthalmology"},{"key":"BF6701689_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/bmj.326.7389.579","volume":"326","author":"MP ten Tusscher","year":"2003","unstructured":"ten Tusscher MP, Jacobs PJ, Busch MJ, de Graaf L, Diemont WL . Bilateral anterior toxic optic neuropathy and the use of infliximab. BMJ 2003; 326: 579.","journal-title":"BMJ"},{"key":"BF6701689_CR13","first-page":"985","volume":"120","author":"R Foroozan","year":"2002","unstructured":"Foroozan R, Buono LM, Sergott RC, Savino PJ . Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol 2002; 120: 985\u2013987.","journal-title":"Arch Ophthalmol"},{"key":"BF6701689_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0002-9394(02)01499-X","volume":"134","author":"C Cursiefen","year":"2002","unstructured":"Cursiefen C, Grunke M, Dechant C, Antoni C, Junemann A, Holbach LM . Multiple bilateral eyelid molluscum contagiosum lesions associated with TNFalpha-antibody and methotrexate therapy. Am J Ophthalmol 2002; 134: 270\u2013271.","journal-title":"Am J Ophthalmol"},{"key":"BF6701689_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/ard.62.9.829","volume":"62","author":"D Baeten","year":"2003","unstructured":"Baeten D, Kruithof E, Van den Bosch F, Van den Bossche N, Herssens A, Mielants H et al. Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease? Ann Rheum Dis 2003; 62: 829\u2013834.","journal-title":"Ann Rheum Dis"},{"key":"BF6701689_CR16","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1378\/chest.124.6.2395","volume":"124","author":"CA Hage","year":"2003","unstructured":"Hage CA, Wood KL, Winer-Muram HT, Wilson SJ, Sarosi G, Knox KS . Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy. Chest 2003; 124: 2395\u20132397.","journal-title":"Chest"},{"key":"BF6701689_CR17","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/rheumatology\/41.8.951","volume":"41","author":"TL Tai","year":"2002","unstructured":"Tai TL, O'Rourke KP, McWeeney M, Burke CM, Sheehan K, Barry M . Pneumocystis carinii pneumonia following a second infusion of infliximab. Rheumatology 2002; 41: 951\u2013952.","journal-title":"Rheumatology"},{"key":"BF6701689_CR18","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1016\/S0002-9270(03)01715-5","volume":"98","author":"G Alcain","year":"2003","unstructured":"Alcain G, Andrade RJ, Queipo de Llano MP, Moreno MJ, Garcia-Cortes M, Franquelo E . Acute leukemia after infliximab therapy. Am J Gastroenterol 2003; 98: 2577.","journal-title":"Am J Gastroenterol"},{"key":"BF6701689_CR19","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/rheumatology\/keg341","volume":"42","author":"Y Menon","year":"2003","unstructured":"Menon Y, Cucurull E, Espinoza LR . Pancytopenia in a patient with scleroderma treated with infliximab. Rheumatology 2003; 42: 1273\u20131274.","journal-title":"Rheumatology"},{"key":"BF6701689_CR20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/ard.62.9.829","volume":"62","author":"D Baeten","year":"2003","unstructured":"Baeten D, Kruithof E, Van den Bosch F, Van den Bossche N, Herssens A, Mielants H et al. Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease? Ann Rheum Dis 2003; 62: 829\u2013834.","journal-title":"Ann Rheum Dis"},{"key":"BF6701689_CR21","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1378\/chest.124.5.2028","volume":"124","author":"SD Roberts","year":"2003","unstructured":"Roberts SD, Wilkes DS, Burgett RA, Knox KS . Refractory sarcoidosis responding to infliximab. Chest 2003; 124: 2028\u20132031.","journal-title":"Chest"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6701689.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701689","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701689.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:19:01Z","timestamp":1684412341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6701689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,24]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["BF6701689"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6701689","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,24]]}}}